Concert Adds Board Member
This article was originally published in Scrip
Concert Pharmaceuticals Inc. has appointed Meghan FitzGerald to its board of directors and she will serve as a member of its compensation committee – effective March 22, 2016. FitzGerald is currently executive vice president of strategy and policy at Cardinal Health Inc. and prior to this she was president of Cardinal Health Specialty Solutions. Previously she was vice president of new markets international division and business development at Medco Health Solutions Inc. FitzGerald has also held various positions at Pfizer Global Pharmaceuticals.